Oh Hyun-Suk, Bae Jong-Myon
Jeju Heathcare Center of Jeju-si, Jeju, Korea.
Department of Preventive Medicine, Jeju National University Scool of Medicine, Jeju, Korea.
Epidemiol Health. 2017 Nov 13;39:e2017053. doi: 10.4178/epih.e2017053. eCollection 2017.
The reported incidence rate of varicella infection in Jeju-do is higher compared with the national average. This study aimed to examine varicella vaccination history and evaluate clinical manifestation of varicella cases in Jeju-do.
Based on the guideline suggested by the Korea Centers for Disease Control and Prevention (KCDC), two epidemic investigations for varicella infection were conducted in the first half of 2017. The history of varicella vaccination was confirmed using the Integrated Control System for Diseases and Health operated by the KCDC.
Out of a total of 60 elementary school children as the study subjects, all had been previously vaccinated against varicella. Twenty cases (33%) showed mild clinical manifestations and no complications.
As the government of Jeju-do has supplied a single-labeled vaccine since 2011, there is a need to evaluate the type of vaccination failure such as primary or secondary.
据报道，济州岛水痘感染的发病率高于全国平均水平。本研究旨在调查济州岛水痘疫苗接种史，并评估水痘病例的临床表现。
根据韩国疾病控制与预防中心（KCDC）建议的指南，于2017年上半年进行了两次水痘感染流行病学调查。通过KCDC运营的疾病与健康综合控制系统确认水痘疫苗接种史。
在总共60名作为研究对象的小学生中，所有人之前都接种过水痘疫苗。20例（33%）表现出轻微的临床表现且无并发症。
由于济州岛政府自2011年以来一直提供单剂量疫苗，有必要评估原发性或继发性等疫苗接种失败的类型。
